{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:35:12Z","timestamp":1790922912464,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,1]]},"DOI":"10.1097\/qai.0b013e31828ece33","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T08:01:52Z","timestamp":1362556912000},"page":"79-86","source":"Crossref","is-referenced-by-count":157,"title":["Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States"],"prefix":"10.1097","volume":"64","author":[{"given":"Lisa A.","family":"Grohskopf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kata L.","family":"Chillag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Gvetadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi M.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal R.","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"O'Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta L.","family":"Ackers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A.","family":"Paxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210131","first-page":"689","article-title":"Thirty years of HIV1981-2011.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-13-20210131","first-page":"65","article-title":"HIV surveillanceUnited States, 1981-2008.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-13-20210131","doi-asserted-by":"crossref","first-page":"e17502","DOI":"10.1371\/journal.pone.0017502","article-title":"; for the HIV Incidence Surveillance Group. Estimated HIV incidence in the United States, 2006-2009.","volume":"6","author":"Prejean","year":"2011","journal-title":"PLoS One"},{"key":"R5-13-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3000391","article-title":". Intermittent prophylaxis with oral Truvada protects macaques from rectal SHIV infection.","volume":"2","author":"Garcia-Lerma","year":"2010","journal-title":"Sci Transl Med"},{"key":"R6-13-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0008829","article-title":". Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice.","volume":"5","author":"Denton","year":"2010","journal-title":"PLoS One"},{"key":"R7-13-20210131","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pmed.0050028","article-title":". Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.","volume":"5","author":"Garcia-Lerma","year":"2008","journal-title":"PloS Med"},{"key":"R8-13-20210131","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/507306","article-title":". Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian immunodeficiency virus in macaques given multiple virus challenges.","volume":"194","author":"Subbarao","year":"2009","journal-title":"J Infect Dis"},{"key":"R9-13-20210131","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0140-6736(12)61235-5","article-title":"FDA paves the way for pre-exposure HIV prophylaxis.","volume":"380","author":"Holmes","year":"2012","journal-title":"Lancet"},{"key":"R10-13-20210131","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":". Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"R11-13-20210131","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"; for the TDF2 Study Group. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"R12-13-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":". Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"R15-13-20210131","first-page":"1","article-title":"Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals (review).","volume":"1","author":"Okwundu","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-13-20210131","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/QAD.0b013e3280b07b33","article-title":". The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first four years.","volume":"21","author":"Nelson","year":"2007","journal-title":"AIDS"},{"key":"R17-13-20210131","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","article-title":". Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.","volume":"23","author":"Labarga","year":"2009","journal-title":"AIDS"},{"key":"R18-13-20210131","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":". Fanconi syndrome and renal failure induced by tenofovir: a first case report.","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R19-13-20210131","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000441-200212000-00011","article-title":"Acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity.","volume":"324","author":"Coca","year":"2002","journal-title":"Am J Med Sci"},{"key":"R20-13-20210131","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2004.03.025","article-title":"Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure.","volume":"117","author":"Rifkin","year":"2004","journal-title":"Am J Med"},{"key":"R21-13-20210131","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00126334-200403010-00007","article-title":". Renal tubular dysfunction associated with tenofovir therapy: report of seven cases.","volume":"35","author":"Peyriere","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-13-20210131","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ki.2010.318","article-title":". Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.","volume":"78","author":"Herlitz","year":"2010","journal-title":"Kidney Int"},{"key":"R23-13-20210131","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/QAD.0b013e32833dfad1","article-title":". Tolerability of HIV postexposure prophylaxis with tenofoviremtricitabine and lopinavirritonavir tablet formulation.","volume":"24","author":"Tosini","year":"2010","journal-title":"AIDS"},{"key":"R24-13-20210131","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/QAI.0b013e318162afcb","article-title":". Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center.","volume":"47","author":"Mayer","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-13-20210131","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1310\/hct0803-164","article-title":". The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naive HIV-1-infected patients.","volume":"8","author":"Cassetti","year":"2007","journal-title":"HIV Clin Trials"},{"key":"R26-13-20210131","doi-asserted-by":"crossref","first-page":"e23688","DOI":"10.1371\/journal.pone.0023688","article-title":". Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco.","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"R31-13-20210131","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice.","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin Ther"},{"key":"R32-13-20210131","first-page":"65","article-title":"Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R33-13-20210131","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/QAD.0b013e328270385a","article-title":". Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.","volume":"21","author":"Dumond","year":"2007","journal-title":"AIDS"},{"key":"R34-13-20210131","doi-asserted-by":"crossref","first-page":"112re4","DOI":"10.1126\/scitranslmed.3003174","article-title":". Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.","volume":"3","author":"Patterson","year":"2011","journal-title":"Sci Transl Med"},{"key":"R35-13-20210131","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00002030-200403260-00010","article-title":". Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high risk behavior.","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"key":"R36-13-20210131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/QAI.0b013e3181e8efe4","article-title":". Packaging PrEP to prevent HIV: an integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice.","volume":"55","author":"Underhill","year":"2010","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e31828ece33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:00:11Z","timestamp":1620957611000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201309010-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31828ece33","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717995256.793475441","asserted-by":"object"}]},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,1]]}}}